Peptoids Market - Global Forecast 2026-2032

The peptoids market is undergoing rapid transformation as organizations shift focus from experimental research to industrial-scale deployment. Emerging trends in automation, analytical rigor, and partnership models are enabling senior leaders to harness peptoids as a versatile, strategic platform for therapeutics, diagnostics, and advanced materials.

Market Snapshot: Peptoids Market Size, Growth, and Outlook

The Peptoids Market grew from USD 70.88 million in 2025 to USD 78.16 million in 2026. It is expected to continue growing at a CAGR of 10.81%, reaching USD 145.45 million by 2032.

Scope & Segmentation

Product Types: Discrete peptoid oligomers for binding or bioactivity, peptoid-based polymers and conjugates geared towards surface function, delivery, or stimuli response.
Synthesis Approaches: Solid-phase and solution-phase synthesis, hybrid assembly methods leveraging robotics, automation, and improved purification for scalable and reproducible manufacturing.
Application Areas: Biomedical therapeutics, diagnostics, research reagents, surface coatings, targeted delivery systems, antifouling layers, and materials with tunable stability and responsiveness.
End User Profiles: Pharmaceutical and biotechnology firms focused on developability and quality alignment; academic and research institutions prioritizing flexible chemistry access; industrial materials users emphasizing durability, performance, and integration.
Regional Coverage: Americas (venture-driven translation and commercial scaling); Europe (quality-centric production, collaborative networks); Asia-Pacific (process-driven commercialization, advanced synthesis adoption); Middle East & Africa (targeted adoption for operational gains).
Technology Drivers: Automated, modular synthesis; property-first sequence design; hybrid biomaterial architectures; analytics pipelines supporting characterization and quality assurance.

Key Takeaways

Peptoids are evolving into a scalable platform, moving beyond early-stage research to address real-world needs in therapeutics, diagnostics, and materials science.
Automation and robotics are accelerating synthesis, driving faster design cycles that enable property-driven molecule selection and improve learning efficiency.
Hybrid systems combining peptoids with other chemistries are expanding application potential but require improvements in analytical comparability and quality standards.
Collaboration across discovery groups, CDMOs, and technology vendors is shortening development timelines by integrating manufacturing considerations earlier in the process.
End-user requirements vary widely: pharma and biotech demand robust documentation, while industrial users emphasize repeatable performance and integration into established workflows.
Suppliers with proven ability to deliver reproducible batches, transparency in impurity profiles, and verified performance are best positioned to win procurement trust.

Tariff Impact: Navigating Regulatory and Supply Chain Friction

Recent United States tariff schedules have introduced heightened uncertainty regarding reagent and equipment costs for peptoids production. This operational friction is visible in R&D and pilot-scale activities, where disrupted sourcing or increased landed prices can restrict exploration and slow iteration. Strategic localization, dual sourcing, and early, costed design decisions are increasingly critical for organizations seeking resilience in procurement. CDMOs and specialty suppliers should emphasize transparency, inventory strength, and supplier diversification to mitigate these evolving risks.

Methodology & Data Sources

This report integrates secondary research mapping the peptoids technology landscape, including synthesis, applications, and regulatory context, with primary validation via industry stakeholder interviews. Senior process chemists, product managers, and procurement executives contributed expertise on quality expectations, sourcing constraints, and operational realities. Insights are cross-verified to address competitive dynamics, supply chain risk, and practical levers for executive decision-making.

Why This Report Matters

Equips senior executives with actionable analysis connecting technology choices, supply risks, and commercialization strategies specific to the peptoids market.
Supports procurement, R&D, and manufacturing leaders in anticipating tariff effects, standardizing analytical practices, and selecting optimal partners for scale-up.
Guides strategic planning by revealing differentiated segment dynamics, regional strengths, and best-practice partnership models for industrializing peptoids.

Conclusion

Peptoids are positioned as a platform technology where manufacturability, supply resilience, and application alignment drive sustainable success. By integrating design, sourcing, and analytics, organizations can transition from technical promise to scalable market outcomes in this dynamic sector.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Peptoids Market, by Type

8.1. Cyclic
8.2. Linear

9. Peptoids Market, by Synthesis Method

9.1. Solid-Phase Synthesis
9.1.1. Boc Chemistry
9.1.2. Fmoc Chemistry
9.2. Solution-Phase Synthesis
9.2.1. Conventional Heating
9.2.2. Microwave-Assisted

10. Peptoids Market, by Application

10.1. Biomedical Research
10.1.1. Biological Assays
10.1.2. Mechanistic Studies
10.2. Diagnostics
10.2.1. Biomarker Detection
10.2.2. Imaging Agents
10.3. Drug Delivery
10.3.1. Controlled Release
10.3.1.1. Hydrogel-Based Carriers
10.3.1.2. Polymer-Based Carriers
10.3.2. Targeted Delivery
10.4. Drug Discovery
10.4.1. High-Throughput Screening
10.4.2. Molecular Modeling
10.5. Tissue Engineering
10.5.1. Cell Adhesion
10.5.2. Scaffold Functionalization

11. Peptoids Market, by End User

11.1. Academic & Research Institutes
11.1.1. Government Laboratories
11.1.2. Universities
11.2. Biotechnology Companies
11.2.1. Diagnostics
11.2.2. Therapeutics
11.3. CROs
11.3.1. Clinical
11.3.2. Preclinical
11.4. Pharmaceutical Companies
11.4.1. Big Pharma
11.4.2. Generic Pharma

12. Peptoids Market, by Region

12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific

13. Peptoids Market, by Group

13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO

14. Peptoids Market, by Country

14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea

15. United States Peptoids Market
16. China Peptoids Market

17. Competitive Landscape

17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abcam plc
17.6. AnaSpec, Inc.
17.7. Apeptide Co., Ltd.
17.8. Bachem Holding AG
17.9. Biomatik Corporation
17.10. Bio-Synthesis, Inc.
17.11. ChemPep Inc.
17.12. ChinaPeptides Co., Ltd.
17.13. CPC Scientific Inc.
17.14. Creative Peptides LLC
17.15. GenScript Biotech Corporation
17.16. GenScript USA Inc.
17.17. GL Biochem Ltd.
17.18. JPT Peptide Technologies GmbH
17.19. Lonza Group AG
17.20. NovoPro Bioscience Co., Ltd.
17.21. Pepscan Presto B.V.
17.22. Peptide 2.0 Inc.
17.23. Peptides International LLC
17.24. Peptones
17.25. Sigma-Aldrich Co. LLC
17.26. SynPeptide Co., Ltd.
17.27. Thermo Fisher Scientific Inc.

List of Figures

FIGURE 1. GLOBAL PEPTOIDS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL PEPTOIDS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL PEPTOIDS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL PEPTOIDS MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL PEPTOIDS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL PEPTOIDS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PEPTOIDS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL PEPTOIDS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PEPTOIDS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES PEPTOIDS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA PEPTOIDS MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL PEPTOIDS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL PEPTOIDS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PEPTOIDS MARKET SIZE, BY CYCLIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL PEPTOIDS MARKET SIZE, BY CYCLIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL PEPTOIDS MARKET SIZE, BY CYCLIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL PEPTOIDS MARKET SIZE, BY LINEAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL PEPTOIDS MARKET SIZE, BY LINEAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL PEPTOIDS MARKET SIZE, BY LINEAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL PEPTOIDS MARKET SIZE, BY BOC CHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL PEPTOIDS MARKET SIZE, BY BOC CHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PEPTOIDS MARKET SIZE, BY BOC CHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PEPTOIDS MARKET SIZE, BY FMOC CHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL PEPTOIDS MARKET SIZE, BY FMOC CHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL PEPTOIDS MARKET SIZE, BY FMOC CHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PEPTOIDS MARKET SIZE, BY CONVENTIONAL HEATING, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PEPTOIDS MARKET SIZE, BY CONVENTIONAL HEATING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PEPTOIDS MARKET SIZE, BY CONVENTIONAL HEATING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL PEPTOIDS MARKET SIZE, BY MICROWAVE-ASSISTED, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL PEPTOIDS MARKET SIZE, BY MICROWAVE-ASSISTED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PEPTOIDS MARKET SIZE, BY MICROWAVE-ASSISTED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PEPTOIDS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL PEPTOIDS MARKET SIZE, BY BIOLOGICAL ASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PEPTOIDS MARKET SIZE, BY BIOLOGICAL ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PEPTOIDS MARKET SIZE, BY BIOLOGICAL ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL PEPTOIDS MARKET SIZE, BY MECHANISTIC STUDIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL PEPTOIDS MARKET SIZE, BY MECHANISTIC STUDIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL PEPTOIDS MARKET SIZE, BY MECHANISTIC STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL PEPTOIDS MARKET SIZE, BY BIOMARKER DETECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL PEPTOIDS MARKET SIZE, BY BIOMARKER DETECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL PEPTOIDS MARKET SIZE, BY BIOMARKER DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL PEPTOIDS MARKET SIZE, BY IMAGING AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL PEPTOIDS MARKET SIZE, BY IMAGING AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL PEPTOIDS MARKET SIZE, BY IMAGING AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL PEPTOIDS MARKET SIZE, BY HYDROGEL-BASED CARRIERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL PEPTOIDS MARKET SIZE, BY HYDROGEL-BASED CARRIERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL PEPTOIDS MARKET SIZE, BY HYDROGEL-BASED CARRIERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL PEPTOIDS MARKET SIZE, BY POLYMER-BASED CARRIERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL PEPTOIDS MARKET SIZE, BY POLYMER-BASED CARRIERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL PEPTOIDS MARKET SIZE, BY POLYMER-BASED CARRIERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL PEPTOIDS MARKET SIZE, BY TARGETED DELIVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL PEPTOIDS MARKET SIZE, BY TARGETED DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL PEPTOIDS MARKET SIZE, BY TARGETED DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL PEPTOIDS MARKET SIZE, BY HIGH-THROUGHPUT SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL PEPTOIDS MARKET SIZE, BY HIGH-THROUGHPUT SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL PEPTOIDS MARKET SIZE, BY HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL PEPTOIDS MARKET SIZE, BY MOLECULAR MODELING, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL PEPTOIDS MARKET SIZE, BY MOLECULAR MODELING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL PEPTOIDS MARKET SIZE, BY MOLECULAR MODELING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL PEPTOIDS MARKET SIZE, BY CELL ADHESION, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL PEPTOIDS MARKET SIZE, BY CELL ADHESION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL PEPTOIDS MARKET SIZE, BY CELL ADHESION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL PEPTOIDS MARKET SIZE, BY SCAFFOLD FUNCTIONALIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL PEPTOIDS MARKET SIZE, BY SCAFFOLD FUNCTIONALIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL PEPTOIDS MARKET SIZE, BY SCAFFOLD FUNCTIONALIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL PEPTOIDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL PEPTOIDS MARKET SIZE, BY GOVERNMENT LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL PEPTOIDS MARKET SIZE, BY GOVERNMENT LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL PEPTOIDS MARKET SIZE, BY GOVERNMENT LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL PEPTOIDS MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL PEPTOIDS MARKET SIZE, BY UNIVERSITIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL PEPTOIDS MARKET SIZE, BY UNIVERSITIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL PEPTOIDS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL PEPTOIDS MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL PEPTOIDS MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL PEPTOIDS MARKET SIZE, BY CROS, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL PEPTOIDS MARKET SIZE, BY CROS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL PEPTOIDS MARKET SIZE, BY CROS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL PEPTOIDS MARKET SIZE, BY CROS, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL PEPTOIDS MARKET SIZE, BY CLINICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL PEPTOIDS MARKET SIZE, BY CLINICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL PEPTOIDS MARKET SIZE, BY CLINICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL PEPTOIDS MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL PEPTOIDS MARKET SIZE, BY PRECLINICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL PEPTOIDS MARKET SIZE, BY PRECLINICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL PEPTOIDS MARKET SIZE, BY BIG PHARMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL PEPTOIDS MARKET SIZE, BY BIG PHARMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL PEPTOIDS MARKET SIZE, BY BIG PHARMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL PEPTOIDS MARKET SIZE, BY GENERIC PHARMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL PEPTOIDS MARKET SIZE, BY GENERIC PHARMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL PEPTOIDS MARKET SIZE, BY GENERIC PHARMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL PEPTOIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS PEPTOIDS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS PEPTOIDS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS PEPTOIDS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
TABLE 139. AMERICAS PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2018-2032 (USD MILLION)
TABLE 140. AMERICAS PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 141. AMERICAS PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
TABLE 142. AMERICAS PEPTOIDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 143. AMERICAS PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 144. AMERICAS PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 145. AMERICAS PEPTOIDS MARKET SIZE, BY CROS, 2018-2032 (USD MILLION)
TABLE 146. AMERICAS PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA PEPTOIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA PEPTOIDS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 152. NORTH AMERICA PEPTOIDS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 155. NORTH AMERICA PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
TABLE 156. NORTH AMERICA PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2018-2032 (USD MILLION)
TABLE 157. NORTH AMERICA PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 158. NORTH AMERICA PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
TABLE 159. NORTH AMERICA PEPTOIDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. NORTH AMERICA PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 161. NORTH AMERICA PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 162. NORTH AMERICA PEPTOIDS MARKET SIZE, BY CROS, 2018-2032 (USD MILLION)
TABLE 163. NORTH AMERICA PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 164. LATIN AMERICA PEPTOIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. LATIN AMERICA PEPTOIDS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 166. LATIN AMERICA PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2032 (USD MILLION)
TABLE 167. LATIN AMERICA PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 168. LATIN AMERICA PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 169. LATIN AMERICA PEPTOIDS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 170. LATIN AMERICA PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2032 (USD MILLION)
TABLE 171. LATIN AMERICA PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 172. LATIN AMERICA PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
TABLE 173. LATIN AMERICA PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2018-2032 (USD MILLION)
TABLE 174. LATIN AMERICA PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 175. LATIN AMERICA PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
TABLE 176. LATIN AMERICA PEPTOIDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 177. LATIN AMERICA PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 178. LATIN AMERICA PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 179. LATIN AMERICA PEPTOIDS MARKET SIZE, BY CROS, 2018-2032 (USD MILLION)
TABLE 180. LATIN AMERICA PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2032 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2032 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2018-2032 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY CROS, 2018-2032 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 198. EUROPE PEPTOIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. EUROPE PEPTOIDS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 200. EUROPE PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2032 (USD MILLION)
TABLE 201. EUROPE PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 202. EUROPE PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 203. EUROPE PEPTOIDS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 204. EUROPE PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2032 (USD MILLION)
TABLE 205. EUROPE PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 206. EUROPE PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
TABLE 207. EUROPE PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2018-2032 (USD MILLION)
TABLE 208. EUROPE PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 209. EUROPE PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
TABLE 210. EUROPE PEPTOIDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 211. EUROPE PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 212. EUROPE PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 213. EUROPE PEPTOIDS MARKET SIZE, BY CROS, 2018-2032 (USD MILLION)
TABLE 214. EUROPE PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 215. MIDDLE EAST PEPTOIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 216. MIDDLE EAST PEPTOIDS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 217. MIDDLE EAST PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2032 (USD MILLION)
TABLE 218. MIDDLE EAST PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 219. MIDDLE EAST PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 220. MIDDLE EAST PEPTOIDS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 221. MIDDLE EAST PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2032 (USD MILLION)
TABLE 222. MIDDLE EAST PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 223. MIDDLE EAST PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
TABLE 224. MIDDLE EAST PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2018-2032 (USD MILLION)
TABLE 225. MIDDLE EAST PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 226. MIDDLE EAST PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
TABLE 227. MIDDLE EAST PEPTOIDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 228. MIDDLE EAST PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 229. MIDDLE EAST PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 230. MIDDLE EAST PEPTOIDS MARKET SIZE, BY CROS, 2018-2032 (USD MILLION)
TABLE 231. MIDDLE EAST PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 232. AFRICA PEPTOIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 233. AFRICA PEPTOIDS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 234. AFRICA PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2032 (USD MILLION)
TABLE 235. AFRICA PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 236. AFRICA PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 237. AFRICA PEPTOIDS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 238. AFRICA PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2032 (USD MILLION)
TABLE 239. AFRICA PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 240. AFRICA PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
TABLE 241. AFRICA PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2018-2032 (USD MILLION)
TABLE 242. AFRICA PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 243. AFRICA PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
TABLE 244. AFRICA PEPTOIDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 245. AFRICA PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 246. AFRICA PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 247. AFRICA PEPTOIDS MARKET SIZE, BY CROS, 2018-2032 (USD MILLION)
TABLE 248. AFRICA PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 249. ASIA-PACIFIC PEPTOIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 250. ASIA-PACIFIC PEPTOIDS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 251. ASIA-PACIFIC PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2032 (USD MILLION)
TABLE 252. ASIA-PACIFIC PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 253. ASIA-PACIFIC PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 254. ASIA-PACIFIC PEPTOIDS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 255. ASIA-PACIFIC PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2032 (USD MILLION)
TABLE 256. ASIA-PACIFIC PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 257. ASIA-PACIFIC PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
TABLE 258. ASIA-PACIFIC PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2018-2032 (USD MILLION)
TABLE 259. ASIA-PACIFIC PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 260. ASIA-PACIFIC PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
TABLE 261. ASIA-PACIFIC PEPTOIDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 262. ASIA-PACIFIC PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 263. ASIA-PACIFIC PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 264. ASIA-PACIFIC PEPTOIDS MARKET SIZE, BY CROS, 2018-2032 (USD MILLION)
TABLE 265. ASIA-PACIFIC PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 266. GLOBAL PEPTOIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 267. ASEAN PEPTOIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 268. ASEAN PEPTOIDS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 269. ASEAN PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2032 (USD MILLION)
TABLE 270. ASEAN PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 271. ASEAN PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 272. ASEAN PEPTOIDS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 273. ASEAN PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2032 (USD MILLION)
TABLE 274. ASEAN PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 275. ASEAN PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
TABLE 276. ASEAN PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2018-2032 (USD MILLION)
TABLE 277. ASEAN PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 278. ASEAN PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
TABLE 279. ASEAN PEPTOIDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 280. ASEAN PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 281. ASEAN PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 282. ASEAN PEPTOIDS MARKET SIZE, BY CROS, 2018-2032 (USD MILLION)
TABLE 283. ASEAN PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 284. GCC PEPTOIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 285. GCC PEPTOIDS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 286. GCC PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2032 (USD MILLION)
TABLE 287. GCC PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 288. GCC PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 289. GCC PEPTOIDS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 290. GCC PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2032 (USD MILLION)
TABLE 291. GCC PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 292. GCC PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
TABLE 293. GCC PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2018-2032 (USD MILLION)
TABLE 294. GCC PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 295. GCC PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
TABLE 296. GCC PEPTOIDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 297. GCC PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 298. GCC PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 299. GCC PEPTOIDS MARKET SIZE, BY CROS, 2018-2032 (USD MILLION)
TABLE 300. GCC PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 301. EUROPEAN UNION PEPTOIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 302. EUROPEAN UNION PEPTOIDS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 303. EUROPEAN UNION PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2032 (USD MILLION)
TABLE 304. EUROPEAN UNION PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 305. EUROPEAN UNION PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 306. EUROPEAN UNION PEPTOIDS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 307. EUROPEAN UNION PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2032 (USD MILLION)
TABLE 308. EUROPEAN UNION PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 309. EUROPEAN UNION PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
TABLE 310. EUROPEAN UNION PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2018-2032 (USD MILLION)
TABLE 311. EUROPEAN UNION PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 312. EUROPEAN UNION PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
TABLE 313. EUROPEAN UNION PEPTOIDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 314. EUROPEAN UNION PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 315. EUROPEAN UNION PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 316. EUROPEAN UNION PEPTOIDS MARKET SIZE, BY CROS, 2018-2032 (USD MILLION)
TABLE 317. EUROPEAN UNION PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 318. BRICS PEPTOIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 319. BRICS PEPTOIDS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 320. BRICS PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2032 (USD MILLION)
TABLE 321. BRICS PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 322. BRICS PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 323. BRICS PEPTOIDS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 324. BRICS PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2032 (USD MILLION)
TABLE 325. BRICS PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 326. BRICS PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
TABLE 327. BRICS PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2018-2032 (USD MILLION)
TABLE 328. BRICS PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 329. BRICS PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
TABLE 330. BRICS PEPTOIDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 331. BRICS PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 332. BRICS PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 333. BRICS PEPTOIDS MARKET SIZE, BY CROS, 2018-2032 (USD MILLION)
TABLE 334. BRICS PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 335. G7 PEPTOIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 336. G7 PEPTOIDS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 337. G7 PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2032 (USD MILLION)
TABLE 338. G7 PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 339. G7 PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 340. G7 PEPTOIDS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 341. G7 PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2032 (USD MILLION)
TABLE 342. G7 PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 343. G7 PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
TABLE 344. G7 PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2018-2032 (USD MILLION)
TABLE 345. G7 PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 346. G7 PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
TABLE 347. G7 PEPTOIDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 348. G7 PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 349. G7 PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 350. G7 PEPTOIDS MARKET SIZE, BY CROS, 2018-2032 (USD MILLION)
TABLE 351. G7 PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 352. NATO PEPTOIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 353. NATO PEPTOIDS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 354. NATO PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2032 (USD MILLION)
TABLE 355. NATO PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 356. NATO PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 357. NATO PEPTOIDS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 358. NATO PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2032 (USD MILLION)
TABLE 359. NATO PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 360. NATO PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
TABLE 361. NATO PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2018-2032 (USD MILLION)
TABLE 362. NATO PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 363. NATO PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
TABLE 364. NATO PEPTOIDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 365. NATO PEP

Companies Mentioned

The key companies profiled in this Peptoids market report include:

Abcam plc
AnaSpec, Inc.
Apeptide Co., Ltd.
Bachem Holding AG
Biomatik Corporation
Bio‑Synthesis, Inc.
ChemPep Inc.
ChinaPeptides Co., Ltd.
CPC Scientific Inc.
Creative Peptides LLC
GenScript Biotech Corporation
GenScript USA Inc.
GL Biochem Ltd.
JPT Peptide Technologies GmbH
Lonza Group AG
NovoPro Bioscience Co., Ltd.
Pepscan Presto B.V.
Peptide 2.0 Inc.
Peptides International LLC
Peptones
Sigma-Aldrich Co. LLC
SynPeptide Co., Ltd.
Thermo Fisher Scientific Inc.

Table Information

Report Attribute	Details
No. of Pages	188
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 78.16 Million
Forecasted Market Value ( USD ) by 2032	$ 145.45 Million
Compound Annual Growth Rate	10.8%
Regions Covered	Global
No. of Companies Mentioned	24

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3437EUR$3,939USD£2,985GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3707EUR$4,249USD£3,220GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5025EUR$5,759USD£4,364GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6081EUR$6,969USD£5,281GBP

Market Snapshot: Peptoids Market Size, Growth, and Outlook

Scope & Segmentation

Key Takeaways

Tariff Impact: Navigating Regulatory and Supply Chain Friction

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Reports

AI-driven Peptide Drug Discovery Platform Market - Global Forecast 2026-2032

Doxorubicin - Global Strategic Business Report

High-throughput Peptide Synthesizer Market - Global Forecast 2026-2032

Peptide Synthesis Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

Oligonucleotide Synthesis Market by Product ((Drugs (ASO, SiRNA), Synthesized Oligos (Product (Primers, Probes)), Type ((Custom, Predesigned), Reagents, Equipment), Application (Therapeutic (Rare Diseases), Research, Diagnostics) - Global Forecast to 2030